Inventor · disambiguated record
Peter G. Milner
Also filed as: MILNER PETER · MILNER PETER G · MILNER PETER GERARD · MILNER PETER H
47 granted patents·16 pending applications·1,304 citations·filing 1990–2025
98Inventor score
Files withARYX THERAPEUTICS16CONJUCHEM INC10Xyra LLC7ARYX THERAPEUTICS INC6CONJUCHEM BIOTECHNOLOGIES INC6
Top patents by PatentIndex Score
63 records- 0198US7256253B2Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood componentsCONJUCHEM BIOTECHNOLOGIES INC·Filed 2005·Granted Aug 14, 2007·105 cites·2 claims
- 0298US6887470B1Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood componentsCONJUCHEM INC·Filed 2000·Granted May 3, 2005·210 cites·9 claims
- 0398US6849714B1Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood componentsCONJUCHEM INC·Filed 2000·Granted Feb 1, 2005·254 cites·13 claims
- 0496US11827631B2Methods for the treatment of gastro-intestinal disordersRENEXXION LLC·Filed 2023·Granted Nov 28, 2023·2 cites·34 claims
- 0595US11759640B2Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2022·Granted Sep 19, 2023·5 cites·13 claims
- 0695US11498918B2Methods for the treatment of gastro-intestinal disordersRENEXXION LLC·Filed 2020·Granted Nov 15, 2022·4 cites·28 claims
- 0795US6706892B1Pulmonary delivery for bioconjugationCONJUCHEM INC·Filed 2000·Granted Mar 16, 2004·151 cites·34 claims
- 0895US6500918B2Conjugate comprising an antinociceptive agent covalently bonded to a blood componentCONJUCHEM INC·Filed 2001·Granted Dec 31, 2002·40 cites·16 claims
- 0994US7601691B2Anti-obesity agentsCONJUCHEM BIOTECHNOLOGIES INC·Filed 2005·Granted Oct 13, 2009·27 cites·39 claims
- 1093US11975202B2Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2023·Granted May 7, 2024·2 cites·20 claims
- 1193US6610825B2Method for alleviating pain or providing an analgesic effect in a patientCONJUCHEM INC·Filed 2001·Granted Aug 26, 2003·27 cites·22 claims
- 1292US9549912B2Methods for treating atrial fibrillationARMETHEON INC·Filed 2013·Granted Jan 24, 2017·18 cites·43 claims
- 1392US6602981B2Antinociceptive agent derivativeCONJUCHEM INC·Filed 2001·Granted Aug 5, 2003·26 cites·14 claims
- 1492US6552046B2Materials and methods for the treatment of gastroesophageal reflux diseaseARYX THERAPEUTICS·Filed 2001·Granted Apr 22, 2003·41 cites·33 claims
- 1591US12257228B2Cardioversion methods using budiodaroneXyra LLC·Filed 2023·Granted Mar 25, 2025·1 cites·24 claims
- 1691US12115373B2Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2023·Granted Oct 15, 2024·1 cites·20 claims
- 1790US12391684B2Pharmaceutical formulations and methods for the treatment of gastrointestinal disordersRENEXXION LLC·Filed 2024·Granted Aug 19, 2025·0 cites·18 claims
- 1890US6680387B2Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosisARYX THERAPEUTICS·Filed 2001·Granted Jan 20, 2004·21 cites·130 claims
- 1988US7090851B1Long lasting fusion peptide inhibitors of viral infectionCONJUCHEM INC·Filed 2000·Granted Aug 15, 2006·29 cites·29 claims
- 2088US6316487B1Compounds for treatment of cardiac arrhythmia synthesis, and methods of useARYX THERAPEUTICS·Filed 2000·Granted Nov 13, 2001·20 cites·34 claims
- 2186US6437092B1Conjugates of opioids and endogenous carriersCONJUCHEM INC·Filed 1998·Granted Aug 20, 2002·33 cites·16 claims
- 2286US6372783B1Enantiomeric compounds for treatment of cardiac arrhythmias and methods of useARYX THERAPEUTICS·Filed 2000·Granted Apr 16, 2002·21 cites·52 claims
- 2385US6362223B1Enantiomeric compounds for treatment of cardiac arrhythmias and methods of useARYX THERAPEUTICS·Filed 2000·Granted Mar 26, 2002·20 cites·52 claims
- 2484US7582301B1Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptidesCONJUCHEM BIOTECHNOLOGIES INC·Filed 2000·Granted Sep 1, 2009·21 cites·47 claims
- 2584US6387914B2Ultrashort acting hypnotic barbituratesARYX THERAPEUTICS·Filed 2001·Granted May 14, 2002·10 cites·38 claims
- 2684US6087375AMethods of treating or preventing thrombosesCONJUCHEM INC·Filed 1999·Granted Jul 11, 2000·48 cites·23 claims
- 2784US5668139AA1 adenosine receptor agonists and antagonistsUNIV FLORIDA·Filed 1995·Granted Sep 16, 1997·49 cites·7 claims
- 2883US6683086B2Ultrashort acting hypnotic barbituratesARYX THERAPEUTICS·Filed 2002·Granted Jan 27, 2004·9 cites·26 claims
- 2981US6683195B2Enantiomeric compounds for treatment of cardiac arrhythmias and methods of useARYX THERAPEUTICS·Filed 2002·Granted Jan 27, 2004·8 cites·40 claims
- 3079US11839768B2Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2023·Granted Dec 12, 2023·0 cites·38 claims
- 3179US5631260AXanthine epoxides as A1 adenosine receptor agonists and antagonistsUNIV FLORIDA·Filed 1994·Granted May 20, 1997·29 cites·12 claims
- 3278USRE42412EMaterials and methods for the treatment of gastroesophageal reflux diseaseARYX THERAPEUTICS INC·Filed 2007·Granted May 31, 2011·2 cites·33 claims
- 3373US7608271B2Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing groupCONJUCHEM BIOTECHNOLOGIES INC·Filed 2004·Granted Oct 27, 2009·5 cites·10 claims
- 3471US6608097B2Materials and methods for the treatment of hypertension and anginaARYX THERAPEUTICS·Filed 2002·Granted Aug 19, 2003·4 cites·14 claims
- 3569US7906482B2Anti-obesity agentsADVANCED DIAGNOSTICS AND DISCOVERY·Filed 2007·Granted Mar 15, 2011·1 cites·48 claims
- 3668US7041673B2Ultrashort acting hypnotic barbituratesARYX THERAPEUTICS INC·Filed 2004·Granted May 9, 2006·2 cites·6 claims
- 3767USRE41289EUltrashort acting hypnotic barbituratesARYX THERAPEUTICS INC·Filed 2007·Granted Apr 27, 2010·0 cites·6 claims
- 3867US2009175821A1Modified therapeutic peptides with extended half-lives in vivoBRIDON DOMINIQUE P·Filed 2007·Application pending·0 cites
- 3964US5736528AN6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonistsUNIV FLORIDA·Filed 1995·Granted Apr 7, 1998·17 cites·10 claims
- 4063US5998387AMethod for using A1 adenosine receptor agonistsUNIV FLORIDA·Filed 1998·Granted Dec 7, 1999·16 cites·23 claims
- 4163US2023372284A1Methods for treating atrial fibrillationsXyra LLC·Filed 2023·Application pending·0 cites
- 4262US2008199483A1Long lasting fusion peptide inhibitors of viral infectionCONJUCHEM BIOTECHNOLOGIES INC·Filed 2007·Application pending·0 cites
- 4361US7022722B2Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosisARYX THERAPEUTICS INC·Filed 2004·Granted Apr 4, 2006·1 cites·260 claims
- 4461US6784199B2Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammalsARYX THERAPEUTICS·Filed 2001·Granted Aug 31, 2004·1 cites·5 claims
- 4560US6114344ALong-acting local anestheticsARYX THERAPEUTICS·Filed 1999·Granted Sep 5, 2000·19 cites·1 claims
- 4660US2008176794A1Long lasting fusion peptide inhibitors of viral infectionCONJUCHEM BIOTECHNOLOGIES INC·Filed 2007·Application pending·0 cites
- 4760US2025281448A1Cardioversion Methods Using BudiodaroneXyra LLC·Filed 2025·Application pending·0 cites
- 4859US6768008B2Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosisARYX THERAPEUTICS·Filed 2001·Granted Jul 27, 2004·1 cites·116 claims
- 4955US2005154216A1Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of useARYX THERAPEUTICS·Filed 2004·Application pending·0 cites
- 5054US6818782B2Enantiomeric compounds for treatment of cardiac arrhythmias and methods of useARYX THERAPEUTICS·Filed 2003·Granted Nov 16, 2004·0 cites·1 claims
Showing the top 50 of 63 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →